HOME >> BIOLOGY >> NEWS
Symposium explores microbial forensics and the investigation of biocrimes

February 16, 2003--Denver, CO--September 11 and the events of October 2001 have focused attention on the threat posed by criminals that may use biological pathogens to do harm--and how to catch them. The massive investigation into the anthrax letters that caused more than 20 cases of rare, inhalation anthrax and at least 5 deaths blended public health and law enforcement strategies in an effort to stop the outbreak and trace the organism. Unfortunately, the perpetrator or perpetrators remain at large. Microbial Forensics: A Scientific Assessment, a symposium at the Annual Meeting of the American Association for the Advancement of Science (AAAS) in Denver, CO, will address the systems, methods and technologies required for the successful investigation of biocrimes that could be directed against individuals, institutions, livestock and crops.

The session on Sunday, February 16, 2:30-5:30 pm, will explore microbial forensics, the emerging discipline that combines principles of public health epidemiology and law enforcement to identify patterns in a disease outbreak, determine the pathogen involved, control its spread and trace the microorganism to its source--the perpetrator(s). Microbial forensics investigations require and use traditional investigative methodology, established molecular techniques and new, advanced methods that still may be under development. Since investigators must consider eventual prosecution and presentation of evidence in the courts, biocrime criminal investigations require careful controls and standards for validation and evaluation of technologies and the data they produce.

Speakers at the American Academy of Microbiology (AAM) sponsored session include organizer Abigail Salyers, Ph.D. ,University of Illinois, Urbana-Champaign, and past president of the American Society for Microbiology, who will provide an overview of microbial forensics. Bruce Budowle, Ph.D., of the F.B.I. will speak on Practical Implications of Microbial
'"/>

Contact: Andrea Lohse
alohse@asmusa.org
202-942-9292
American Society for Microbiology
16-Feb-2003


Page: 1 2

Related biology news :

1. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
2. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
3. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
4. Health of worlds sea lions the focus of Wakefield Symposium
5. Chemical signals health of brain cells Symposium
6. Final Alert: 16th EORTC NCI AACR Symposium
7. 16th EORTC NCI AACR Symposium
8. Symposium to tackle questions of genetic engineering and biodiversity
9. Fostering Diversity in the Sciences Symposium
10. Annual Chemical Biology Symposium at Yale May 14, 2004
11. Symposium relates long-term ecological research to ecosystem management

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ACEA Biosciences, ... its Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer ... providing an update on the phase I/II clinical trials for AC0010 in patients with ...
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only way to ... technology experience. All three tenets were on display at the 2nd Annual DrugDev User ... 40 sponsor, CRO and site organizations to discuss innovation and the future of clinical ...
(Date:12/2/2016)... , December 2, 2016 The ... 2021, growing at a CAGR of 7.3% during the forecast period ... hospitals and diagnostic laboratories segment accounted for the largest share of ... ... report on global immunohistochemistry (IHC) market spread across 225 pages, profiling ...
(Date:11/30/2016)... Nov. 30, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" ... PBT.U), is excited to announce the formation of ... developing preclinical ophthalmology assets through proof of concept. ... created by Portage Pharmaceuticals Limited and being developed ... surface and anterior segment diseases. This agent has ...
Breaking Biology Technology:
Cached News: